Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?

[1]  G. P. Studzinski,et al.  Cooperation between antioxidants and 1,25‐dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP‐1/Egr‐1 pathway , 2005, Journal of cellular physiology.

[2]  M. S. Murthy,et al.  Carnitine medium/long chain acyltransferase of microsomes seems to be the previously cloned ∼54 kDa protein of unknown function , 1993, Molecular and Cellular Biochemistry.

[3]  H. Karlic,et al.  Do blood cells mimic gene expression profile alterations known to occur in muscular adaptation to endurance training ? , 2005, European Journal of Applied Physiology.

[4]  S. Aizawa,et al.  Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation. , 2004, Experimental hematology.

[5]  B. Horisberger,et al.  Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey , 2004, Bone Marrow Transplantation.

[6]  B. K. Oppenlander,et al.  Analysis of Primitive CD34− and CD34+ Hematopoietic Cells from Adults: Gain and Loss of CD34 Antigen by Undifferentiated Cells Are Closely Linked to Proliferative Status in Culture , 2004, Stem cells.

[7]  K. Takenaka,et al.  Peripheral blood circulating immature cell counts predict CD34+ cell yields in G‐CSF‐induced PBPC mobilization in healthy donors , 2004, Transfusion.

[8]  G. van Zant,et al.  The role of stem cells in aging. , 2003, Experimental hematology.

[9]  M. Pfeilstöcker,et al.  Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes , 2003, Journal of Molecular Medicine.

[10]  N. Lee,et al.  Large‐volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: Predictors of CD34+ cell yield and collection efficiency , 2003, Journal of clinical apheresis.

[11]  J. Briones,et al.  Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. , 2003, Haematologica.

[12]  A. Gratwohl,et al.  Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey , 2002, Bone Marrow Transplantation.

[13]  M. Pfeilstöcker,et al.  Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Gα16 and 5′-lipoxygenase , 2002, Annals of Hematology.

[14]  S. Seeber,et al.  Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy , 2002, Annals of Hematology.

[15]  H. Karlic,et al.  Dietary L-carnitine Stimulates Carnitine Acyltransferases in the Liver of Aged Rats , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  H. Kawasaki,et al.  Serum Soluble IL-6 Receptor Levels During the Mobilization of Stem Cells to Peripheral Blood , 2002, Leukemia & lymphoma.

[17]  M. Weghofer,et al.  Quantitative analysis of immune-mediated stimulation of tumor necrosis factor-alpha in macrophages measured at the level of mRNA and protein synthesis , 2001, Annals of Hematology.

[18]  R. Storb,et al.  Hematopoietic responses to stress conditions in young dogs compared with elderly dogs. , 2001, Blood.

[19]  S. Glück,et al.  The CD3−16+56+ NK cell count independently predicts autologous blood stem cell mobilization , 2001, Bone Marrow Transplantation.

[20]  J. McGarry.  Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between. , 2001, Biochemical Society transactions.

[21]  F. R. van der Leij,et al.  Molecular enzymology of carnitine transfer and transport. , 2001, Biochimica et biophysica acta.

[22]  P H Hénon,et al.  Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment. , 2001, Journal of biological regulators and homeostatic agents.

[23]  Y. Gazitt,et al.  High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue. , 2000, Journal of hematotherapy & stem cell research.

[24]  A. Bacigalupo.  Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT) , 2000, Bone Marrow Transplantation.

[25]  R. Ramsay.  The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. , 2000, Biochemical Society transactions.

[26]  B. Pollock,et al.  Characterization and Outcome of “Hard to Mobilize” Lymphoma Patients Undergoing Autologous Stem Cell Transplantation , 2000, Leukemia & lymphoma.

[27]  R. Sabit,et al.  Haematopoietic stem cell transplantation. , 2000, Transfusion science.

[28]  Goldman,et al.  Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children , 1999, British journal of haematology.

[29]  M. Gordon,et al.  Reconstruction of the Hematopoietic System after Stem Cell Transplantation , 1998 .

[30]  T. Kirkwood,et al.  The origins of human ageing. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[31]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[32]  R. Hargreaves,et al.  When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. S. Murthy,et al.  Carnitine medium/long chain acyltransferase of microsomes seems to be the previously cloned approximately 54 kDa protein of unknown function. , 1993, Molecular and cellular biochemistry.

[34]  L. Bieber,et al.  The medium-chain carnitine acyltransferase activity associated with rat liver microsomes is malonyl-CoA sensitive. , 1990, Archives of biochemistry and biophysics.

[35]  H. Gerhartz,et al.  Clonogenic assays and engraftment in allogeneic bone marrow transplantation. , 1986, Bone marrow transplantation.

[36]  N. Tolbert,et al.  Comparison of the carnitine acyltransferase activites from rat liver peroxisomes and microsomes. , 1976, Archives of biochemistry and biophysics.